rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2005-9-12
|
pubmed:abstractText |
Our objective was to evaluate the influence of polymorphisms at codons 49 and 389 of the beta1-adrenergic receptor (beta1-AR) on the response to beta-blockers and outcome in patients with dilated cardiomyopathy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0009-9236
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
78
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
221-31
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16153393-Adrenergic beta-Antagonists,
pubmed-meshheading:16153393-Aged,
pubmed-meshheading:16153393-Amino Acid Substitution,
pubmed-meshheading:16153393-Cardiomyopathy, Dilated,
pubmed-meshheading:16153393-Codon,
pubmed-meshheading:16153393-Cohort Studies,
pubmed-meshheading:16153393-DNA,
pubmed-meshheading:16153393-Dose-Response Relationship, Drug,
pubmed-meshheading:16153393-Female,
pubmed-meshheading:16153393-Genotype,
pubmed-meshheading:16153393-Glycine,
pubmed-meshheading:16153393-Humans,
pubmed-meshheading:16153393-Male,
pubmed-meshheading:16153393-Middle Aged,
pubmed-meshheading:16153393-Polymorphism, Genetic,
pubmed-meshheading:16153393-Prospective Studies,
pubmed-meshheading:16153393-Receptors, Adrenergic, beta-1,
pubmed-meshheading:16153393-Serine,
pubmed-meshheading:16153393-Survival Rate,
pubmed-meshheading:16153393-Treatment Outcome
|
pubmed:year |
2005
|
pubmed:articleTitle |
Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
|
pubmed:affiliation |
Wallenberg Laboratory for Cardiovascular Research and Department of Primary Health Care, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden. yvonne.magnusson@wlab.gu.se
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|